Search results for "ANTIFUNGAL"

showing 10 items of 348 documents

Assessment of the Antimicrobial Activity and the Entomocidal Potential of Bacillus thuringiensis Isolates from Algeria.

2017

This work represents the first initiative to analyze the distribution of B. thuringiensis in Algeria and to evaluate the biological potential of the isolates. A total of 157 isolates were recovered, with at least one isolate in 94.4% of the samples. The highest Bt index was found in samples from rhizospheric soil (0.48) and from the Mediterranean area (0.44). Most isolates showed antifungal activity (98.5%), in contrast to the few that had antibacterial activity (29.9%). A high genetic diversity was made evident by the finding of many different crystal shapes and various combinations of shapes within a single isolate (in 58.4% of the isolates). Also, over 50% of the isolates harbored cry1, …

0301 basic medicineAntifungalStaphylococcus aureusmedicine.drug_classHealth Toxicology and Mutagenesis030106 microbiologyBacterial ToxinsBiological pest controlBacillus thuringiensisBiologyToxicologyArticleMicrobiology03 medical and health sciencesB. thuringiensisAnti-Infective AgentsBacterial ProteinsBacillus thuringiensismedicineEscherichia colibiocontrolGeneSoil MicrobiologyGenetic diversitycryChitinasesFungi<i>B. thuringiensis</i>; antibacterial; antifungal; <i>cry</i>; <i>vip3</i>; chitinase; biocontrolAntimicrobialbiology.organism_classificationCryptochromesantibacterialHexosaminidasesGenes BacterialAlgeriachitinaseChitinasePseudomonas aeruginosavip3biology.proteinMicroscopy Electron ScanningAntibacterial activityantifungalToxins
researchProduct

Deletion of GLX3 in Candida albicans affects temperature tolerance, biofilm formation and virulence.

2018

Candida albicans is a predominant cause of fungal infections in mucosal tissues as well as life-threatening bloodstream infections in immunocompromised patients. Within the human body, C. albicans is mostly embedded in biofilms, which provides increased resistance to antifungal drugs. The glyoxalase Glx3 is an abundant proteomic component of the biofilm extracellular matrix. Here, we document phenotypic studies of a glx3Δ null mutant concerning its role in biofilm formation, filamentation, antifungal drug resistance, cell wall integrity and virulence. First, consistent with its function as glyoxalase, the glx3 null mutant showed impaired growth on media containing glycerol as the carbon sou…

0106 biological sciencesHot TemperatureMutantAntifungal drugHyphaeVirulence01 natural sciencesApplied Microbiology and BiotechnologyMicrobiologyMicrobiology03 medical and health sciencesFilamentationCell Wall010608 biotechnologyCandida albicansAnimalsCandida albicans030304 developmental biology0303 health sciencesMice Inbred BALB CbiologyVirulenceBiofilmWild typeCandidiasisGeneral Medicinebiology.organism_classificationAldehyde OxidoreductasesSurvival AnalysisCorpus albicansDisease Models AnimalBiofilmsGene DeletionHeat-Shock ResponseFEMS yeast research
researchProduct

Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study

2017

This study evaluated the independent contribution of voriconazole to the development of squamous cell carcinoma (SCC) in lung transplant recipients, by attempting to account for important confounding factors, particularly immunosuppression. This international, multicenter, retrospective, cohort study included adult patients who underwent lung transplantation during 2005-2008. Cox regression analysis was used to assess the effects of voriconazole and other azoles, analyzed as time-dependent variables, on the risk of developing biopsy-confirmed SCC. Nine hundred lung transplant recipients were included. Median follow-up time from transplantation to end of follow-up was 3.51 years. In a Cox re…

Lung DiseasesMaleOncologylung diseaseAntifungal AgentsSkin Neoplasmsmedicine.medical_treatment030230 surgeryTHERAPY030207 dermatology & venereal diseases0302 clinical medicinelung transplantation/pulmonologypatient safetyEPIDEMIOLOGYMedicineImmunology and AllergyPharmacology (medical)malignant [complication]RISKHazard ratioImmunosuppressionMiddle AgedPrognosisinfection and infectious agents - fungalPRACTICE GUIDELINEScomplication: malignantCarcinoma Squamous Cellantifungal [antibiotic]FemaleLung Transplantationmedicine.drugCohort studyAdultmedicine.medical_specialtyAdolescentinfectious diseaseSOCIETYANTIFUNGAL PROPHYLAXISclinical research/practiceArticleYoung Adult03 medical and health sciencesantibiotic: antifungal; clinical research/practice; complication: malignant; health services and outcomes research; infection and infectious agents - fungal; infectious disease; lung disease; lung transplantation/pulmonology; patient safety; Immunology and Allergy; Transplantation; Pharmacology (medical)LONG-TERM VORICONAZOLEInternal medicineHumansLung transplantationEXPOSUREAgedRetrospective StudiesVoriconazoleTransplantationSKIN-CANCERbusiness.industryProportional hazards modelRetrospective cohort studyantibiotic: antifungalhealth services and outcomes researchTransplant RecipientsSurgeryTransplantationRECIPIENTSVoriconazolebusinessFollow-Up Studies
researchProduct

Antibacterial and Antifungal Activities of Acetonic Extract from Paullinia cupana Mart Seeds

2013

The antibacterial and antifungal activities of the acetone extract from Paullinia cupana var. sorbilis Mart. (Sapindaceae) seeds, commonly called guarana, were assessed against selected bacterial and fungal strains. We tested the extract against both standard American Type Culture Collection (ATCC) and clinically isolated (CI) bacterial strains and three fungal strains. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values for bacteria and MIC and minimum fungicidal concentration for fungi were determined. The extract showed an activity against the nine bacterial strains tested, both CI and ATCC strains (MIC comprised between 32 and 128 μm/mL and MBC bet…

AntifungalAntifungal Agentsmedicine.drug_classPlant ScienceAntibacterial effectMicrobial Sensitivity TestsSapindaceaeAntifungalBiochemistryAnalytical ChemistryMicrobiologyMinimum inhibitory concentrationfoodmedicinePaulliniaPaullinia cupanaMinimum fungicidal concentrationSettore BIO/15 - Biologia FarmaceuticaPaullinia cupanaMinimum bactericidal concentrationbiologyTraditional medicinePlant ExtractsOrganic ChemistrySettore CHIM/06 - Chimica Organicabiology.organism_classificationfood.foodAnti-Bacterial AgentsAntibacterialSeedsBacteria
researchProduct

Physical factors affecting the production of amylase from Bacillus species isolated from natural environment

2014

The aim of conducted research was to determine influence of metabolites produced by Pseudomonas fluorescens on the growth of 4 phytopathogenic strains of Rhizoctonia solani marked R1, R2, R3 and R4 which infect sugar beetroot. The antagonistic properties were assessed with the culture-plate method on PDA medium for P. fluorescens cultured for 4, 6 8, 10 and 24 hours at 25 o C for 5 days. The fungistatic activity of P. fluorescens was determined against the growth rate index and the rate of mycelial growth inhibition. Obtained results prove, that Rhizoctonia spp. strains were both sensitive and resistant to metabolites produced by P. fluorescens. The highest inhibition of the linear growth o…

Rhizoctonia solaniantifungal activityPseudomonas fluorescensgrowth rate indexEcological Chemistry and Engineering. A
researchProduct

Dying with or because of invasive fungal infection? The role of immunity exhaustion on patient outcome

2016

De Rosa et al. considered clinical scores, biomarkers and their combination as useful aids for an early antifungal treatment and advocated the adoption of de-escalation therapy in an antifungal stewardship approach as a possible key for a better management of these patients. Authors considered the high burden of invasive fungal infections in terms of patient outcomes and costs and focused on current strategies for their optimization.

0301 basic medicineAntifungalmedicine.medical_specialtyEmergency Medicine; Anesthesiology and Pain Medicinebusiness.industrymedicine.drug_class030106 microbiology030208 emergency & critical care medicinemedicine.diseasesepsis fungal infectionOutcome (game theory)03 medical and health sciences0302 clinical medicineAnesthesiology and Pain MedicineAcquired immunodeficiency syndrome (AIDS)ImmunityAntifungal Treatment CORTEGIANI vs. DE ROSA: DEBATE Second RoundEmergency MedicineMedicineMED/41 - ANESTESIOLOGIAbusinessIntensive care medicine
researchProduct

Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia

2017

BACKGROUND: Invasive fungal infections are important causes of morbidity and mortality among critically ill patients. Early institution of antifungal therapy is pivotal for mortality reduction. Starting a targeted antifungal therapy after culture positivity and fungi identification requires a long time. Therefore, alternative strategies (globally defined as 'untargeted antifungal treatments') for antifungal therapy institution in patients without proven microbiological evidence of fungal infections have been discussed by international guidelines. This review was originally published in 2006 and updated in 2016. This updated review provides additional evidence for the clinician dealing with …

Medicine General & Introductory Medical Sciences0301 basic medicineAntifungalmedicine.medical_specialtyAntifungal AgentsNeutropeniaSystemic mycosismedicine.drug_classCritical Illness030106 microbiologyMycoseNeutropeniaPlacebo03 medical and health sciences0302 clinical medicinemedicineAntifungal AgentHumansInvasive Fungal InfectionMED/41 - ANESTESIOLOGIAIntensive care medicinebusiness.industryCritically illMedicine (all)030208 emergency & critical care medicineGeneral Medicinemedicine.diseaseMycosesClinical questionCritical illnessCritical IllnebusinessInvasive Fungal InfectionsHumanJAMA
researchProduct

Wykorzystanie antagonistycznych właściwości Bacillus subtilis wobec Rhizoctonia solani

2017

auksynyaktywność przeciwgrzybowaRhizoctonia solaniauxinsantifungal activityBacillus subtilisProceedings of ECOpole
researchProduct

Antifungal peptides produced by Bacillus amyloliquefaciens AG1 active against grapevine fungal pathogens

2012

Abstract Antifungal metabolites produced by Bacillus amyloliquefaciens AG1, previously isolated from wood of grapevine with “esca syndrome”, were studied. The crude protein extract (CPE) obtained from culture supernatant fluid by precipitation with ammonium sulfate was assayed against many grapevine fungal pathogens. B. amyloliquefaciens strain AG1 showed a broad spectrum of antifungal activity, inhibiting mycelial growth in vitro of all tested fungal microorganisms. The metabolites contained in CPE were heat stable and remained active over a wide pH range (2–10). Their activity was not affected by proteolytic or glycolytic enzymes. Tricine- SDS-polyacrylamide gel electrophoresis revealed a…

Gel electrophoresisAmmonium sulfatebiologyStrain (chemistry)Bacillus amyloliquefaciensAntibiosisBiocontrolSettore AGR/12 - Patologia VegetaleBacillus amyloliquefacienFungal pathogenFungusbiology.organism_classificationApplied Microbiology and BiotechnologyIn vitroMicrobiologyBacillus amyloliquefaciens . Biocontrol . Fungal pathogen . Grapevine . Antifungal peptideAntifungal peptidechemistry.chemical_compoundchemistryGrapevineMycelium
researchProduct

Obtaining antioxidants and natural preservatives from food by-products through fermentation: A review

2021

Industrial food waste has potential for generating income from high-added-value compounds through fermentation. Solid-state fermentation is promising to obtain a high yield of bioactive compounds while requiring less water for the microorganism’s growth. A number of scientific studies evinced an increase in flavonoids or phenolics from fruit or vegetable waste and bioactive peptides from cereal processing residues and whey, a major waste of the dairy industry. Livestock, fish, or shellfish processing by-products (skin, viscera, fish scales, seabass colon, shrimp waste) also has the possibility of generating antioxidant peptides, hydrolysates, or compounds through fermentation. These bioacti…

0106 biological sciencesPreservativeAntioxidantantioxidantMicroorganismmedicine.medical_treatmentFermentation industries. Beverages. AlcoholFood spoilagePlant ScienceAntifungal01 natural sciencesBiochemistry Genetics and Molecular Biology (miscellaneous)Hydrolysate0404 agricultural biotechnology010608 biotechnologymedicineBioreactorFood sciencefermentationFood by-productsTP500-660Chemistryfood and beverages04 agricultural and veterinary sciences040401 food scienceFood wasteFermentationFermentationfood by-productsAntioxidantantifungalFood ScienceFermentation
researchProduct